ADR Biomedical Holdings Inc. (TYO:3750)

ADR Biomedical Holdings Revenue

ADR Biomedical Holdings had revenue of 57.00M JPY in the quarter ending June 30, 2026, with 850.00% growth. This brings the company's total for the last twelve months to 101.00M, up 13.48% year-over-year. In the fiscal year ending March 31, 2026, ADR Biomedical Holdings had annual revenue of 50.00M, down -59.02%. That makes ADR Biomedical Holdings the 44,252nd largest company in the world by revenue and 3,866th in Japan.

• Revenue (ttm): 101.00M
• Revenue Growth: +13.48%
• P/S Ratio: 66.65
• Revenue / Employee: 7.77M
• Employees: 13
• Market Cap: 6.73B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Medical Business 95.64M 78.3%
• Real Asset Business 26.57M 21.7%

Fiscal year ended Mar 31, 2025 See the full ADR Biomedical Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	50.00M	-72.00M	-59.02%
Mar 31, 2025	122.00M	-1.44B	-92.18%
Mar 31, 2024	1.56B	-584.00M	-27.24%
Mar 31, 2023	2.14B	809.00M	60.60%
Mar 31, 2022	1.34B	-53.00M	-3.82%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error